7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

NextCure, Inc
(NASDAQ:NXTC) 

NXTC stock logo

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment o...

IPO Price: $15 (May 08, 2019)
Full Time Employees: 69
CEO: Michael S. Richman  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
NextCure Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 030.6361.2791.9122.53153.17183.8214.44
NextCure Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.1-1.8-1.5-1.2-0.9-0.6-0.30
NextCure Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.18-1.87-1.56-1.25-0.93-0.62-0.310
NextCure Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.961.912.873.824.785.736.69
NextCure P/S ratio ttm
202109 202110 202111 202112 202201 202202 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01,517.63,035.194,552.796,070.397,587.999,105.5810,623.18Billion
NextCure (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.99-0.84-0.7-0.56-0.42-0.28-0.140
NextCure P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.080.160.240.330.410.490.57
No extra charts and metrics for this ticker.